SEC Form 4 · accession 0001127602-19-002481
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gloria M McCarthy
Officer — EVP & Chief Administrative Off
Period of report
Jan 18, 2019
Accepted (ET)
Jan 22, 2019 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 18, 2019 | M | 7,700 | $265.00 | A | 46,456 | D | |
| Common Stock | Jan 18, 2019 | S | 7,700 | $265.00 | D | 38,756 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $146.93 | Jan 18, 2019 | M | 7,700 | D | — | Mar 2, 2025 | Common Stock | 7,700 | 9,062 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.
- F2The option represents a right to purchase a total of 16,762 shares, and is exercisable in six semi-annual installments, with four installments of 2,794 shares each and two installments of 2,793 shares each, beginning on September 2, 2015, which is the six-month anniversary of option grant date.